User profiles for Chengzi I. Kaku
 | Chengzi I. KakuScripps Research Verified email at scripps.edu Cited by 756 |
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
The recurrent zoonotic spillover of coronaviruses (CoVs) into the human population
underscores the need for broadly active countermeasures. We employed a directed evolution …
underscores the need for broadly active countermeasures. We employed a directed evolution …
Recall of preexisting cross-reactive B cell memory after Omicron BA. 1 breakthrough infection
Understanding immune responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
breakthrough infection will facilitate the development of next-generation …
breakthrough infection will facilitate the development of next-generation …
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
A comprehensive understanding of the kinetics and evolution of the human B cell response
to SARS-CoV-2 infection will facilitate the development of next-generation vaccines and …
to SARS-CoV-2 infection will facilitate the development of next-generation vaccines and …
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
Heterologous prime-boost immunization strategies have the potential to augment COVID-19
vaccine efficacy. We longitudinally profiled severe acute respiratory syndrome coronavirus …
vaccine efficacy. We longitudinally profiled severe acute respiratory syndrome coronavirus …
[HTML][HTML] Evolution of antibody immunity following Omicron BA. 1 breakthrough infection
Understanding the longitudinal dynamics of antibody immunity following heterologous SAR-CoV-2
breakthrough infection will inform the development of next-generation vaccines. Here…
breakthrough infection will inform the development of next-generation vaccines. Here…
A broad and potent neutralization epitope in SARS-related coronaviruses
Many neutralizing antibodies (nAbs) elicited to ancestral severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
P Schmidt, K Narayan, Y Li, CI Kaku… - Science Translational …, 2023 - science.org
Multiple studies of vaccinated and convalescent cohorts have demonstrated that serum
neutralizing antibody (nAb) titers correlate with protection against coronavirus disease 2019 (…
neutralizing antibody (nAb) titers correlate with protection against coronavirus disease 2019 (…
[HTML][HTML] Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron
Studying the antibody response to SARS-CoV-2 informs on how the human immune system
can respond to antigenic variants as well as other SARS-related viruses. Here, we …
can respond to antigenic variants as well as other SARS-related viruses. Here, we …
Revisiting an IgG Fc loss-of-function experiment: the role of complement in HIV broadly neutralizing antibody b12 activity
The role of the complement system in HIV-1 immunity and pathogenesis is multifaceted, and
an improved understanding of complement activities mediated by HIV-1-specific antibodies …
an improved understanding of complement activities mediated by HIV-1-specific antibodies …
[HTML][HTML] An engineered antibody with broad protective efficacy in murine models of SARS and COVID-19
CG Rappazzo, VT Longping, CI Kaku, D Wrapp… - BioRxiv, 2020 - ncbi.nlm.nih.gov
The recurrent zoonotic spillover of coronaviruses (CoVs) into the human population underscores
the need for broadly active countermeasures. Here, we employed a directed evolution …
the need for broadly active countermeasures. Here, we employed a directed evolution …